Introduction
============

Intraocular lenses (IOLs) replace the dioptric power of the lens after cataract surgery. Traditional IOLs are the monofocals that have a single focal length being able to provide good visual function to the patient and can correct ametropias to improve distance vision.[@b1-opth-11-1393] However, pseudophakic patients with monofocal IOLs end up needing glasses to compensate for the loss of accomodation.[@b2-opth-11-1393],[@b3-opth-11-1393]

Multifocal IOLs offer the patient an opportunity to correct the effects of presbyopia after cataract surgery. Despite the optical evolution and technology in lens manufacture, possible side effects of multifocal IOLs include glare, halos and other dysphotopsias; reduced contrast sensitivity (CS) and unsatisfactory uncorrected visual acuity.[@b4-opth-11-1393],[@b5-opth-11-1393]

Most commercially available multifocal IOLs have two optical zones: one that provides distance vision and the second that provides near vision, known as bifocal IOLs.[@b6-opth-11-1393] More recently, trifocal IOLs have been released, providing a third intermediate focal point. As an even greater division of light occurs to create one more focus, there is concern about the increase in undesirable optical phenomena with trifocal lenses.[@b7-opth-11-1393] Some studies have already shown that improved vision at intermediate distances is created at the expense of worsening far and near vision quality.[@b8-opth-11-1393] The greatest challenge of multifocal IOLs is to provide good vision quality at all distances while minimizing undesirable phenomena.[@b9-opth-11-1393]

Acrysof^®^ IQ Restor^®^ (SV25T0 and SN6AD1) (Alcon Laboratories, Inc., Forth-Worth, TX, USA) IOLs have, respectively, near addition power of +2.5 and +3.0 diopters in the IOL plane. These are two diffractive bifocal lenses with apodized design in the anterior surface. Usually, they are implanted bilaterally providing good visual acuity at far and near (50 and 40 cm, respectively) distances. However, the patient is likely to experience some limitation to see clearly at distances other than that determined by the IOL's focal points. The SV25T0 demonstrated a lower incidence of visual disturbances in comparison with SN6AD1. Some surgeons associate the characteristics of each lens by performing the contralateral (also known as a "blended") implant strategy, which consists of implanting SV25T0 IOL in the dominant eye and SN6AD1 in the nondominant eye. It has already been shown that this technique is able to increase the useful range of near vision.[@b9-opth-11-1393],[@b10-opth-11-1393]

The Acrysof IQ PanOptix (TFNT00) is a trifocal IOL made of hydrophobic acrylic. It has a trifocal nonapodized design and provides a near sight point at 40 cm and far sight similar to the SN6AD1 model, presenting the additional benefit of an intermediate focal point of 60 cm.[@b11-opth-11-1393],[@b12-opth-11-1393]

At our center, the blended implantation is done as routine in patients requiring improved intermediate vision. With the availability of trifocal IOLs, there is a need for comparison between the two strategies.

The purpose of this study is to compare the visual results of near, intermediate and far vision, CS and the defocus curve between SV25T0 (dominant eye) and SN6AD1 (nondominant eye) blended implantation and the bilateral TFNT00 (Alcon Laboratories, Inc.) implantation.

Methods
=======

This study was conducted in accordance with the ethics principles of the Declaration of Helsinki and was approved by the Brasília Ophthalmologic Hospital Ethics Research Committee, Brasília, Brazil.

This was a prospective, nonrandomized, comparative study of consecutive cases.

The study involved 20 subjects, 15 females (75%) and five males (25%). Patient characteristics are summarized in [Table 1](#t1-opth-11-1393){ref-type="table"}.

All patients underwent an uneventful cataract surgery followed by IOL implantation by a single surgeon (W.T.H) between July 2016 and October 2016. Surgery of the second eye was performed within 30 days of the first. Informed consent was obtained from all patients prior to data collection. Analysis of the optical function and CS was performed and compared between the bilateral implantation of TNFT00 and the blended implantation of SV25T0 in the dominant eye and the SN6AD1 in the nondominant eye. Exclusion criteria were, 1) existence of any corneal, retinal or optic nerve disease, 2) previous eye surgery, 3) illiteracy, 4) previous corneal refractive surgery, 5) high axial myopia, 6) postoperative corneal astigmatism of \>1.00 cylindrical diopter (D), and 7) intraoperative or postoperative complications.

All patients underwent complete preoperative and 1-month (after second eye surgery) postoperative ophthalmological examination, including biomicroscopy, tonometry, retinoscopy, fundoscopy, near, intermediate and far visual acuity, defocus curve and CS. Uncorrected near (UNVA, 40 cm), uncorrected intermediate (UIVA, 60 cm) and corrected and uncorrected distance (CDVA, UDVA, 4 m) binocular visual acuity were measured using the Early Treatment Diabetic Retinopathy Study reading charts (ETDRS; Vector Vision, Ltd, Greenville, OH, USA and Precision Vision, IL, USA).

The evaluation included the testing of binocular CS under photopic and mesopic conditions (with and without glare) using the CSV-1000 chart (Vector Vision, Inc., Greenville, OH, USA) with spatial frequencies ranging between 1.5 and 18 cycles/degree (cpd) at 2.5 m. Glare was generated from CSV-1000's halogen lamps and set at the factory-calibrated level automatically. A table provided by the manufacturer was used to convert the data into base 10 logarithms for statistical analysis.

Binocular defocus curves were obtained in corrected distance visual acuity with the same ETDRS charts, at intervals of 0.50 spherical diopters from −5.00 to 0.00 D. Levels of luminance were measured using Gossen starlite 2 (Gossen, Nürnberg, Germany). Photopic conditions were defined as \~85 candelas/meter^2^ (cd/m^2^) and ambient luminance was defined as inferior to 21.25 lux.

Significance was tested using the analysis of variance and Tukey's test for parametric variables and Kruskal--Wallis test for nonparametric variables, adjusting to a level of significance of 5% (*P*\<0.05) and using software R version 3.3.2 for analysis (Foundation for Statistical Computing, Vienna, Austria).

Results
=======

All patients were submitted to the second eye surgery after 1 week and before 30 days of the first surgery. Average time interval was 11 days (8--22 days) in the trifocal group and 12 days (8--28) for the blend group. There were no significant differences between the two groups (*P*\>0.5).

Average preoperative CDVA was better in the blend group than in the trifocal group (0.24 vs 0.15 logMAR, *P*=0.073), although this difference was not statistically significant ([Table 1](#t1-opth-11-1393){ref-type="table"}). Groups achieved homogeneity in age, gender, IOL diopter and postoperative spherical equivalent (SE) ([Tables 1](#t1-opth-11-1393){ref-type="table"} and [2](#t2-opth-11-1393){ref-type="table"}).

The trifocal group showed better results for CS under photopic conditions at 6 (*P*=0.046), 12 (*P*\<0.01) and 18 cpd (*P*\<0.01) without glare. At 3 cpd there was no statistically significant difference. With glare, there were no significant differences between groups at 3, 6 and 12 cpd. At 18 cpd, the trifocal group showed better CS (*P*\<0.01) ([Figures 1](#f1-opth-11-1393){ref-type="fig"} and [2](#f2-opth-11-1393){ref-type="fig"}).

Under mesopic conditions without glare there was no significant difference in CS between groups. With glare, the blend group performed better at 3 (*P*\<0.01), 6 (*P*=0.014) and 12 cpd (*P*\<0.01). At 1.5 cpd, the trifocal group showed better CS (*P*=0.023) ([Figures 3](#f3-opth-11-1393){ref-type="fig"} and [4](#f4-opth-11-1393){ref-type="fig"}).

Defocus curves in the two groups achieved a trifocal pattern, with the trifocal group achieving statistically significant better visual acuity from −2.00 D to plano and at −3.50 ([Figure 5](#f5-opth-11-1393){ref-type="fig"}).

Discussion
==========

Our results show that both the trifocal bilateral implantation and the blended implantation strategies are capable of achieving good CDVA, UIVA and UNVA as demonstrated in other studies comparing other trifocal lenses.[@b13-opth-11-1393]--[@b15-opth-11-1393] As postoperative SE approached emmetropia and was not significantly different between groups, both treatments have shown efficacy and provided independence from glasses.

Analysis of CDVA, UDVA, UIVA and UNVA highlighted advantages of the PanOptix bilateral implant (*P*\<0.05) in our study. In a recently published study comparing FineVision and PanOptix, the authors demonstrated a very good performance of both IOLs with no difference in distance vision. At 80 cm, FineVision patients had better VA. From 60 cm and nearer PanOptix showed better results with a defocus curve very similar to our study.[@b16-opth-11-1393] Studies conducted on different commercial models of trifocal IOLs have reported good distance, intermediate and near VAs. In a study reporting 44 eyes of 22 patients implanted with FineVision (PhysIOL, Liège, Belgium) trifocal IOL, a full range of adequate vision was achieved, CS was satisfactory and there were no significant adverse photic phenomena after implantation.[@b17-opth-11-1393] In 54 eyes of 27 patients who underwent AT LISA trifocal IOL implantation following phacoemulsification, good distance, intermediate and near VAs (0.10 logMAR or better), a high patient satisfaction and a high spectacle independence were reported.[@b18-opth-11-1393]

Some publications have reported great visual outcomes with the blended strategy. Gundersen and Potvin[@b8-opth-11-1393] compared the blend strategy against bilateral FineVision trifocal IOL. Although there were no significant differences in near, intermediate or distant corrected VAs, four points of defocus curves showed significant dominance of the trifocal IOL. Nuijts et al compared the blend with the bilateral implantation of SV25T0, achieving similar results between groups, with better, but not statistically significant, average VA at near distance for the blended group. In both studies, defocus curves of the blended group were very similar to our study.[@b8-opth-11-1393],[@b9-opth-11-1393]

The trifocal group showed excellent visual acuity through a considerably big interval of vergence (−0.1 and +0.1 logMAR from −2.50 to plano), suggesting that this strategy could have a better tolerance of a hyperopic residual refraction error when compared to the blended implantation.

In the present study, the best levels of photopic CS were achieved at 6 cpd ([Figures 1](#f1-opth-11-1393){ref-type="fig"} and [2](#f2-opth-11-1393){ref-type="fig"}). The trifocal group showed statistically significantly better performance in CS without glare. When we analyze at mesopic condition, the highest levels of CS were seen in the lowest frequencies (1.5 and 3.0 cpd) in both groups. Without glare, there was no statistically significant difference between groups. With glare, the blend group was better at 1.5, 3.0 and 6 cpd while the trifocal group was better at 12 cpd. Nuijts et al have also achieved the highest level of CS at 6 cpd, although they have found no statistical significance.[@b9-opth-11-1393] Mastropasqua et al compared the SV25T0/SN6AD1 blend with the bilateral implantation of each lens separately, having found no statistically significant difference between groups and achieved highest CS at 3 cpd. This could be explained by a diminished tendency of dysphotopic phenomena regarding SV25T0.[@b19-opth-11-1393]

Limitations of the study include the small number of patients selected, which reduces statistical power of the analysis. In addition, the testing distances applied favor the trifocal group, considering the manufacturer data.

In conclusion, both the strategies were effective in enabling good vision for far, intermediate and short distances with the trifocal group exhibiting better overall performance. More studies are needed to analyze different criteria and to increase the number of patients to improve statistical power.
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###### 

Demographic characteristics of patients by group

                         Trifocal                 Blend                    *P*-value
  ---------------------- ------------------------ ------------------------ -----------
  Gender (male/female)   2/10                     4/10                     0.35
  Age, years             64.2±8.34 (51--70)       61.9±4.45 (56--71)       0.32
  Pre-CDVA               0.24±0.18 (0.54--0.00)   0.15±0.13 (0.44--0.00)   0.073

**Note:** Data are shown as mean ± SD (lower bound--upper bound).

**Abbreviation:** Pre-CDVA, preoperative corrected distant visual acuity.

###### 

Descriptive measures for implanted IOL refractive power (diopters), postoperative, spherical equivalent, postoperative visual acuities and pupillometry for Trifocal and Blend groups

  Measurement              Mean ± SD (min--max)         *P*-value                   
  ------------------------ ---------------------------- --------------------------- -----------------------------------------------------
  IOL diopter              22.23±1.51 (20.00--25.50)    21.30±1.38 (19.00--23.50)   0.123
  UDVA                     0.01±0.04 (−0.04 to 0.10)    0.08±0.05 (−0.02 to 0.16)   \<0.01[\*](#tfn4-opth-11-1393){ref-type="table-fn"}
  UIVA                     0.14±0.05 (0.06--0.22)       0.22±0.06 (0.12--0.34)      \<0.01[\*](#tfn4-opth-11-1393){ref-type="table-fn"}
  UNVA                     −0.03±0.04 (−0.1 to 0.06)    0.07±0.03 (0.04--0.12)      \<0.01[\*](#tfn4-opth-11-1393){ref-type="table-fn"}
  SE                       −0.07±0.23 (−0.50 to 0.25)   0.03±0.19 (−0.38 to 0.38)   0.226
  CDVA                     0.01±0.06 (−0.10 to 0.16)    0.04±0.06 (−0.06 to 0.14)   \<0.01[¥](#tfn3-opth-11-1393){ref-type="table-fn"}
  Pupillometry (mesopic)   4.78±0.64 (3.50--5.50)       5.08±0.75 (3.50--6.0)       0.423

**Notes:**

= analysis of variance;

= Kruskal--Wallis.

**Abbreviations:** CDVA, postoperative corrected distance visual acuity; IOL, intraocular lens; SE, postoperative spherical equivalent; UDVA, postoperative uncorrected distance visual acuity; UIVA, postoperative uncorrected intermediate visual acuity; UNVA, postoperative uncorrected near visual acuity.
